Skip to main content

Table 1.

Primers used for PCR and sequencing for screening of mutations

Gene Sense Antisense Sequencing
PIK3CA
Exon 9 5′‐GATTGGTTCTTTCCTGTCTCTG‐3′ 5′‐CCACAAATATCAATTTACAACCATTG‐3′ 5′‐TTGCTTTTTCTGTAAATCATCTGTG‐3′
Exon 20 5′‐TGGGGTAAAGGGAATCAAAAG‐3′ 5′‐CCTATGCAATCGGTCTTTGC‐3′ 5′‐TGACATTTGAGCAAAGACCTG‐3′
EGFR
Exon 18 5′‐TCAGAGCCTGTGTTTCTACCAA‐3′ 5′‐TGGTCTCACAGGACCACTGATT‐3′ 5′‐TCCAAATGAGCTGGCAAGTG‐3′
Exon 19 5′‐AAATAATCAGTGTGATTCGTGGAG‐3′ 5′‐GAGGCCAGTGCTGTCTCTAAGG‐3′ 5′‐GTGCATCGCTGGTAACATCC‐3′
Exon 21 5′‐GCAGCGGGTTACATCTTCTTTC‐3′ 5′‐CAGCTCTGGCTCACACTACCAG‐3′ 5′‐GCTCAGAGCCTGGCATGAA‐3′
PTEN
Exon 1 5′‐GCAGCTTCTGCCACTTCTCT‐3′ 5′‐CATCCGTCTACTCCCACGTT‐3′
Exon 2 5′‐CTCCAGCTATAGTGGGGAAAA‐3′ 5′‐CTGTATCCCCCTGAAGTCCA‐3′
Exon 3 5′‐TGGTGGCTTTTTGTTTGTTT‐3′ 5′‐CATGAATCTGTGCCAACAATG‐3′
Exon 4 5′‐AAAGATTCAGGCAATGTTTGTT‐3′ 5′‐TCTCACTCGATAATCTGGATGAC‐3′
Exon 5 5′‐GGAATCCAGTGTTTCTTTTAAATACC‐3′ 5′‐TCCAGGAAGAGGAAAGGAAAA‐3′
Exon 6 5′‐ATGGCTACGACCCAGTTACC‐3′ 5′‐TTGGCTTCTTTAGCCCAATG‐3′
Exon 7 5′‐TGCTTGAGATCAAGATTGCAG‐3′ 5′‐GCCATAAGGCCTTTTCCTTC‐3′
Exon 8–1 5′‐GTGCAGATAATGACAAGGAATA‐3′ 5′‐ACACATCACATACATACAAGTC‐3′
Exon 8–2 5′‐TTAAATATGTCATTTCATTTCTTTTTC‐3′ 5′‐CTTTGTCTTTATTTGCTTTGT‐3′
Exon 9 5′‐TGTTCATCTGCAAAATGGAAT‐3′ 5′‐CAAGTGTCAAAACCCTGTGG‐3′
HHS Vulnerability Disclosure